|
WO2014183147A1
|
|
Apricitabine and nrti combination therapy
|
|
WO2013071353A1
|
|
Apricitabine and pi combination therapy
|
|
CN102336751A
|
|
Novel antiviral agent
|
|
EP2291377A1
|
|
Imidazopyrimidinones and uses thereof
|
|
CA2729649A1
|
|
Thiazopyrimidinones and uses thereof
|
|
NZ590126A
|
|
Compounds having antiviral properties
|
|
CN101842370A
|
|
A process for chiral resolution of 2-substituted 4-substituted 1,3-oxathiolanes
|
|
ZA200904321B
|
|
Bicyclic pyrimidinones and uses thereof
|
|
KR20090097194A
|
|
Bicyclic pyrimidinones and uses thereof
|
|
CN101484449A
|
|
Integrase inhibitors 3
|
|
WO2007124545A1
|
|
Integrase inhibitors - 2
|
|
WO2007124544A1
|
|
Integrase inhibitors - 1
|
